Search research articles
Contact Us
Filters
Showing results (161-170 of 184) with videos related to
Page
of 19
Sort By:
Journal for Immunotherapy of Cancer
|
May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Investigational New Drugs
|
May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
Emilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.
Cancer Discovery
|
November 30, 2018
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
Alexander Drilon, Siqing Fu, Manish R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Daniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014
Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report
Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2026
Early ctDNA stratifies survival in locally advanced and oligometastatic lung cancer treated with radiotherapy
Ayesha Hashmi, Jessica Linford, Pradeep S Chauhan, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 184) with videos related to
Sort By:
Page
of 19
Journal for Immunotherapy of Cancer
|
May 31, 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Investigational New Drugs
|
May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
Emilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.
Cancer Discovery
|
November 30, 2018
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
Alexander Drilon, Siqing Fu, Manish R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Daniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014
Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report
Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2026
Early ctDNA stratifies survival in locally advanced and oligometastatic lung cancer treated with radiotherapy
Ayesha Hashmi, Jessica Linford, Pradeep S Chauhan, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Page
of 19